ANNUAL REPORT 2021

LUNDBECK ANNUAL REPORT 2021 = CONTENTS Board of Directors* 43/111 LARS SØREN RASMUSSEN Chairman • Born 1959 • Elected 2013 ■ Considered independent Lundbeck committees • Audit Committee (M) ■ Remuneration & Nomination Committee (C) Directorships Coloplast A/S (C) ⚫ Danish Industry (DI) Committee on Diversity (C) Danish Committee of Corporate Governance (C) • Life Science Council under the Danish Ministry of Industry, Business and Financial Affairs (C) Holding of shares 20,000 LENE SKOLE-SØRENSEN Deputy Chairman • Born 1959 • CEO, Lundbeck Foundation • Elected 2015 • Considered dependent Lundbeck committees • Remuneration & Nomination Committee (M) ⚫ Scientific Committee (M) Directorships •ALK-Abelló A/S (DC) •Falck A/S (DC) Ørsted A/S (DC) • Tryg A/S (M) • Tryg Forsikring A/S (M) Holding of shares 8,808 LARS ERIK HOLMQVIST • Born 1959 • Elected 2015 • Considered dependent Lundbeck committees • Audit Committee (M) Directorships • Biovica International AB (C) Lundbeck Foundation (M) •ALK-Abelló A/S (M) - Vitrolife AB (M) • Naka UK topco Ltd. (M) Holding of shares 15,000 JEREMY MAX LEVIN • Bom 1953 • CEO, Ovid Therapeutics • Elected 2017 • Considered independent • Lundbeck committees ⚫ Scientific Committee (C) Directorships • Ovid Therapeutics (C) • Opthea (C) • BIO (the Biotechnology Innovation • Organization) (M) Holding of shares None JEFFREY BERKOWITZ • Born 1966 • CEO, Real Endpoints • Elected 2018 . Considered independent Lundbeck committees • Remuneration & Nomination Committee (M) Scientific Committee (M) Directorships ⚫ PharmaTwoB (C) ⚫ Click Therapeutics (M) • Esperion Therapeutics, Inc. (M) ⚫ Zealand Pharma A/S (M) Uniphar PLC (M) Holding of shares None Per 31.12 2021 C=Chairman, DC Deputy Chairman, M = Member "For more information about the Board of Directors and their competencies, please visit https://www.lundbeck.com/global/about-us/our-leadership/board-of-directors

View entire presentation